Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ilaria Depetris
Observed names:
I. Depetris,
ILARIA DEPETRIS
Institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Fondazione Ricerca Molinette
Observed institutions:
Azienda Ospedaliera Citta' della Salute e della Scienza di Torino,
Fondazione Ricerca Molinette,
Istituto Oncologico Veneto,
Ospedale Civile Di Ivrea,
Candiolo Cancer Institute,
University of Turin
show all 6
ORCID:
0000-0001-6748-4992
Observed ORCID:
0000-0001-6748-4992
OpenAlex ID:
A5017812334
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
2016
·
Andrea Sartore-Bianchi
, Livio Trusolino
, et al.
·
The Lancet Oncology
·
1,113
PDF
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
2020
·
Giuseppe Nicolò Fanelli
, Carlo Alberto Dal Pozzo
, et al.
·
Cancer Cell International
·
129
PDF
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes
2020
·
Fotios Loupakis
, Ilaria Depetris
, et al.
·
The Oncologist
·
125
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer
2023
·
Joris van de Haar
, Xuhui Ma
, et al.
·
Nature Medicine
·
96
PDF
Fluoropyrimidine-induced cardiotoxicity
2018
·
Ilaria Depetris
, Donatella Marino
, et al.
·
Critical Reviews in Oncology/Hematology
·
78
A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study
2019
·
Fotios Loupakis
, Rossana Intini
, et al.
·
European Journal of Cancer
·
71
PDF
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
2024
·
Brigida Anna Maiorano
, Massimo Di Maio
, et al.
·
JAMA Network Open
·
67
The prognostic nutritional index predicts survival and response to first‐line chemotherapy in advanced biliary cancer
2019
·
Massimiliano Salati
, Roberto Filippi
, et al.
·
Liver International
·
62
Efficacy and Safety of Immune Checkpoint Inhibitors in Patients with Microsatellite Instability-High End-Stage Cancers and Poor Performance Status Related to High Disease Burden
2020
·
Filippo Pietrantonio
, Fotios Loupakis
, et al.
·
The Oncologist
·
52
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
2019
·
Fotios Loupakis
, Giulia Maddalena
, et al.
·
Journal for ImmunoTherapy of Cancer
·
37
PDF
Fluoropyrimidine‑induced cardiotoxicity in colorectal cancer patients: a prospective observational trial (CHECKPOINT)
2022
·
Pasquale Lombardi
, Giacomo Aimar
, et al.
·
Oncology Reports
·
19
PDF
Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion
2021
·
Roberto Filippi
, Ilaria Depetris
, et al.
·
Expert Opinion on Pharmacotherapy
·
18
Clinicians’ Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, “Real-Life”, Case-Control Study
2021
·
Alessandro Parisi
, Giampiero Porzio
, et al.
·
Clinical Colorectal Cancer
·
12
Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report
2016
·
Elisabetta Fenocchio
, Ilaria Depetris
, et al.
·
BMC Cancer
·
12
PDF
Rationale for the use of metronomic chemotherapy in gastrointestinal cancer
2018
·
Roberto Filippi
, Pasquale Lombardi
, et al.
·
Expert Opinion on Pharmacotherapy
·
11
Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
2022
·
Stefano Granieri
, Christian Cotsoglou
, et al.
·
Cancers
·
10
PDF
Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience
2019
·
Elisabetta Fenocchio
, Federica Colombi
, et al.
·
Cancers
·
10
PDF
TEAM Study: Upfront Docetaxel Treatment in Patients With Metastatic Hormone-Sensitive Prostate Cancer: A Real-World, Multicenter, Retrospective Analysis
2023
·
Chiara Pisano
, Fabio Turco
, et al.
·
Clinical Genitourinary Cancer
·
7
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
2025
·
Lorena Incorvaia
, Mattia Puglisi
, et al.
·
The Oncologist
·
6
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study
2021
·
Alessandro Parisi
, Alessio Cortellini
, et al.
·
Frontiers in Oncology
·
6
PDF
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
2021
·
Paolo Antonetti
, Maria Concetta Fargnoli
, et al.
·
Supportive Care in Cancer
·
4
Fluoropyrimidine-induced cardiotoxicity in colorectal cancer patients: Preliminary data from the prospective observational CHECKPOINT trial (NCT02665312)
2019
·
P. Lombardi
, G. Aimar
, et al.
·
Annals of Oncology
·
2
PDF
Improvement of metastatic colorectal cancer patient survival: Single institution experience
2018
·
E. Fenocchio
, F. Colombi
, et al.
·
Annals of Oncology
·
2
Rapid symptomatic and radiological response to pembrolizumab–lenvatinib in a 30-year-old man with metastatic sarcomatoid renal cell carcinoma not otherwise specified and extensive osteolytic bone disease
2026
·
Giorgia Novero
, Isabella Cavaglià
, et al.
·
Drugs in Context
·
1
Global Real‐World Outcomes of Olaparib in Metastatic Castration‐Resistant Prostate Cancer Patients With Homologous Recombination Repair Alterations
2026
·
Lorena Incorvaia
, Daniele Santini
, et al.
·
International Journal of Cancer
·
1
PDF
Show more works
View as search
Works count:
38
Citation count:
1,952
H-index:
12
I10-index:
17
Year
Topic
Type